54 related articles for article (PubMed ID: 2575000)
21. Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood.
Yaich L; Dupont WD; Cavener DR; Parl FF
Cancer Res; 1992 Jan; 52(1):77-83. PubMed ID: 1345763
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism.
Hill SM; Fuqua SA; Chamness GC; Greene GL; McGuire WL
Cancer Res; 1989 Jan; 49(1):145-8. PubMed ID: 2562795
[TBL] [Abstract][Full Text] [Related]
23. Somatic change in the estrogen receptor gene associated with altered expression of the progesterone receptor.
Wanless C; Barker S; Puddefoot JR; Panahy C; Goode AW; Vinson GP; Phillips IR
Anticancer Res; 1991; 11(1):139-42. PubMed ID: 2018347
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry.
Helin HJ; Helle MJ; Kallioniemi OP; Isola JJ
Cancer; 1989 May; 63(9):1761-7. PubMed ID: 2649227
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the estrogen receptor gene structure in human breast cancer.
Koh EH; Ro J; Wildrick DM; Hortobagyi GN; Blick M
Anticancer Res; 1989; 9(6):1841-5. PubMed ID: 2576351
[TBL] [Abstract][Full Text] [Related]
26. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.
BLOOM HJ; RICHARDSON WW
Br J Cancer; 1957 Sep; 11(3):359-77. PubMed ID: 13499785
[No Abstract] [Full Text] [Related]
27. The problem of nonresponding estrogen receptor-positive patients with advanced breast cancer.
Maass H; Jonat W; Stolzenbach G; Trams G
Cancer; 1980 Dec; 46(12 Suppl):2835-7. PubMed ID: 7470229
[TBL] [Abstract][Full Text] [Related]
28. The value of estrogen and progesterone receptors in the treatment of breast cancer.
Osborne CK; Yochmowitz MG; Knight WA; McGuire WL
Cancer; 1980 Dec; 46(12 Suppl):2884-8. PubMed ID: 7448733
[TBL] [Abstract][Full Text] [Related]
29. Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy.
Manni A; Arafah B; Pearson OH
Cancer; 1980 Dec; 46(12 Suppl):2838-41. PubMed ID: 7448730
[TBL] [Abstract][Full Text] [Related]
30. Quantitative estrogen receptor analyses: the response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval.
Lippman ME; Allegra JC
Cancer; 1980 Dec; 46(12 Suppl):2829-34. PubMed ID: 7448729
[TBL] [Abstract][Full Text] [Related]
31. Statistical methods in cancer research. Volume I - The analysis of case-control studies.
Breslow NE; Day NE
IARC Sci Publ; 1980; (32):5-338. PubMed ID: 7216345
[No Abstract] [Full Text] [Related]
32. The syndromes of androgen resistance.
Griffin JE; Wilson JD
N Engl J Med; 1980 Jan; 302(4):198-209. PubMed ID: 6985704
[No Abstract] [Full Text] [Related]
33. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading.
Parl FF; Schmidt BP; Dupont WD; Wagner RK
Cancer; 1984 Nov; 54(10):2237-42. PubMed ID: 6488142
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D3--resistant fibroblasts have immunoassayable 1,25-dihydroxyvitamin D3 receptors.
Pike JW; Dokoh S; Haussler MR; Liberman UA; Marx SJ; Eil C
Science; 1984 May; 224(4651):879-81. PubMed ID: 6326262
[TBL] [Abstract][Full Text] [Related]
36. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.
Feinberg AP; Vogelstein B
Anal Biochem; 1983 Jul; 132(1):6-13. PubMed ID: 6312838
[TBL] [Abstract][Full Text] [Related]
37. The histopathological evaluation of human breast cancers in correlation with estrogen receptor values.
Parl FF; Wagner RK
Cancer; 1980 Jul; 46(2):362-7. PubMed ID: 6248193
[TBL] [Abstract][Full Text] [Related]
38. Cytogenetic analysis in human breast carcinoma. I. Nine cases in the diploid range investigated using direct preparations.
Rodgers CS; Hill SM; Hultén MA
Cancer Genet Cytogenet; 1984 Oct; 13(2):95-119. PubMed ID: 6090007
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptors and breast cancer response to adrenalectomy.
Jensen EV; Block GE; Smith S; Kyser K; DeSombre ER
Natl Cancer Inst Monogr; 1971 Dec; 34():55-70. PubMed ID: 5140877
[No Abstract] [Full Text] [Related]
40. A new mechanism for steroid unresponsiveness: loss of nuclear binding activity of a steroid hormone receptor.
Gehring U; Tomkins GM
Cell; 1974 Nov; 3(3):301-6. PubMed ID: 4373173
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
